Early Nitric Oxide is Not Associated with Improved Outcomes in Congenital Diaphragmatic Hernia

Overview

Journal Pediatr Res

Specialties Biology
Pediatrics

Date 2023 Feb 1

PMID 36725908

Authors

Caroline Y Noh

Valerie Y Chock

Shazia Bhombal

Enrico Danzer

Neil Patel

Alex Dahlen

Matthew T Harting

Kevin P Lally

Ashley H Ebanks

Krisa P Van Meurs

Affiliations

Soon will be listed here.

Abstract

Background: Inhaled nitric oxide (iNO) is widely used for the management of infants with congenital diaphragmatic hernia (CDH); however, evidence of benefit is limited.

Methods: This is a multicenter cohort study using data from the Congenital Diaphragmatic Hernia Study Group between 2015 and 2020. The impact of early iNO use in the first 3 days of life prior to ECLS use on mortality or ECLS use was explored using multivariate logistic regression models and subgroup analyses.

Results: Of the 1777 infants, 863 (48.6%) infants received early iNO treatment. Infants receiving iNO had lower birth weight, larger defect size, more severe pulmonary hypertension, and abnormal ventricular size and function. After controlling for these factors, early iNO use was associated with increased mortality (aOR 2.06, 95% CI 1.05-4.03, P = 0.03) and increased ECLS use (aOR 3.44, 95% CI 2.11-5.60, P < 0.001). Subgroup analyses after stratification by echocardiographic characteristics and defect size revealed no subgroup with a reduction in mortality or ECLS use.

Conclusions: Use of iNO in the first 3 days of life prior to ECLS was not associated with a reduction in mortality or ECLS use in either the regression models or the subgroup analyses. The widespread use of iNO in this vulnerable population requires reconsideration.

Impact: Evidence to support widespread use of iNO for infants with congenital diaphragmatic hernia is limited. The use of iNO in the first 3 days of life was associated with significantly increased mortality and ECLS use. Stratification by echocardiographic characteristics and defect size did not reveal a subgroup that benefited from iNO. Even the subset of patients with R-to-L shunts at both ductal and atrial levels, a surrogate for elevated pulmonary arterial pressures in the absence of significantly decreased LV compliance, did not benefit from early iNO use. Early iNO therapy was of no benefit in the management of acute pulmonary hypertension in infants with congenital diaphragmatic hernia, supporting reconsideration of its use in this population.

Citing Articles

Enhancing the Survival of Congenital Diaphragmatic Hernia: Quality Improvement Initiative With a Multidisciplinary Extracorporeal Membrane Oxygenation Team Approach.

Lee B, Jung E, Kim H, Kim S, Jeong J, Lee H J Korean Med Sci. 2024; 39(48):e300.

PMID: 39688328 PMC: 11650333. DOI: 10.3346/jkms.2024.39.e300.

Hemodynamic management of congenital diaphragmatic hernia: the role of targeted neonatal echocardiography.

Surak A, Mahgoub L, Ting J World J Pediatr Surg. 2024; 7(2):e000790.

PMID: 38737963 PMC: 11086387. DOI: 10.1136/wjps-2024-000790.

Management advances for congenital diaphragmatic hernia: integrating prenatal and postnatal perspectives.

Baschat A, Desiraju S, Bernier M, Kunisaki S, Miller J Transl Pediatr. 2024; 13(4):643-662.

PMID: 38715680 PMC: 11071032. DOI: 10.21037/tp-23-602.

Diagnosis, management and long term cardiovascular outcomes of phenotypic profiles in pulmonary hypertension associated with congenital diaphragmatic hernia.

Chaudhari T, Schmidt Sotomayor N, Maheshwari R Front Pediatr. 2024; 12:1356157.

PMID: 38590769 PMC: 10999638. DOI: 10.3389/fped.2024.1356157.

Multicentre, randomised controlled trial of physiological-based cord clamping versus immediate cord clamping in infants with a congenital diaphragmatic hernia (PinC): statistical analysis plan.

Horn-Oudshoorn E, Vermeulen M, Knol R, Bout-Rebel R, Te Pas A, Hooper S Trials. 2024; 25(1):198.

PMID: 38509614 PMC: 10953116. DOI: 10.1186/s13063-024-08027-7.

References

Levin D . Morphologic analysis of the pulmonary vascular bed in congenital left-sided diaphragmatic hernia. J Pediatr. 1978; 92(5):805-9. DOI: 10.1016/s0022-3476(78)80162-0. View

Lath N, Galambos C, Rocha A, Malek M, Gittes G, Potoka D . Defective pulmonary innervation and autonomic imbalance in congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol. 2011; 302(4):L390-8. PMC: 3774131. DOI: 10.1152/ajplung.00275.2011. View

Irish M, Glick P, Russell J, Kapur P, Bambini D, Holm B . Contractile properties of intralobar pulmonary arteries and veins in the fetal lamb model of congenital diaphragmatic hernia. J Pediatr Surg. 1998; 33(6):921-8. DOI: 10.1016/s0022-3468(98)90675-3. View

Patel N, Lally P, Kipfmueller F, Massolo A, Luco M, Van Meurs K . Ventricular Dysfunction Is a Critical Determinant of Mortality in Congenital Diaphragmatic Hernia. Am J Respir Crit Care Med. 2019; 200(12):1522-1530. DOI: 10.1164/rccm.201904-0731OC. View

Heiss K, Manning P, Oldham K, Coran A, Polley Jr T, Wesley J . Reversal of mortality for congenital diaphragmatic hernia with ECMO. Ann Surg. 1989; 209(2):225-30. PMC: 1493900. DOI: 10.1097/00000658-198902000-00014. View

Schumacher R, Roloff D, Chapman R, Snedecor S, Bartlett R . Extracorporeal membrane oxygenation in term newborns. A prospective cost-benefit analysis. ASAIO J. 1993; 39(4):873-9. View

Kays D . ECMO in CDH: Is there a role?. Semin Pediatr Surg. 2017; 26(3):166-170. DOI: 10.1053/j.sempedsurg.2017.04.006. View

Langham Jr M, Kays D, Beierle E, Chen M, Mullet T, Rieger K . Twenty years of progress in congenital diaphragmatic hernia at the University of Florida. Am Surg. 2003; 69(1):45-52. View

Jancelewicz T, Langham Jr M, Brindle M, Stiles Z, Lally P, Dong L . Survival Benefit Associated With the Use of Extracorporeal Life Support for Neonates With Congenital Diaphragmatic Hernia. Ann Surg. 2020; 275(1):e256-e263. DOI: 10.1097/SLA.0000000000003928. View

10.

Clark R, Kueser T, Walker M, Southgate W, Huckaby J, Perez J . Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med. 2000; 342(7):469-74. DOI: 10.1056/NEJM200002173420704. View

11.

Campbell B, Herbst K, Briden K, Neff S, Ruscher K, Hagadorn J . Inhaled nitric oxide use in neonates with congenital diaphragmatic hernia. Pediatrics. 2014; 134(2):e420-6. DOI: 10.1542/peds.2013-2644. View

12.

Putnam L, Tsao K, Morini F, Lally P, Miller C, Lally K . Evaluation of Variability in Inhaled Nitric Oxide Use and Pulmonary Hypertension in Patients With Congenital Diaphragmatic Hernia. JAMA Pediatr. 2016; 170(12):1188-1194. DOI: 10.1001/jamapediatrics.2016.2023. View

13.

Kinsella J, Neish S, Ivy D, Shaffer E, Abman S . Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr. 1993; 123(1):103-8. DOI: 10.1016/s0022-3476(05)81551-3. View

14.

Lawrence K, Monos S, Adams S, Herkert L, Peranteau W, Munson D . Inhaled Nitric Oxide Is Associated with Improved Oxygenation in a Subpopulation of Infants with Congenital Diaphragmatic Hernia and Pulmonary Hypertension. J Pediatr. 2019; 219:167-172. DOI: 10.1016/j.jpeds.2019.09.052. View

15.

Ferguson D, Gupta V, Lally P, Luco M, Tsao K, Lally K . Early, Postnatal Pulmonary Hypertension Severity Predicts Inpatient Outcomes in Congenital Diaphragmatic Hernia. Neonatology. 2021; 118(2):147-154. DOI: 10.1159/000512966. View

16.

Byrne F, Keller R, Meadows J, Miniati D, Brook M, Silverman N . Severe left diaphragmatic hernia limits size of fetal left heart more than does right diaphragmatic hernia. Ultrasound Obstet Gynecol. 2015; 46(6):688-94. DOI: 10.1002/uog.14790. View

17.

Kailin J, Dhillon G, Maskatia S, Cass D, Shamshirsaz A, Mehollin-Ray A . Fetal left-sided cardiac structural dimensions in left-sided congenital diaphragmatic hernia - association with severity and impact on postnatal outcomes. Prenat Diagn. 2017; 37(5):502-509. DOI: 10.1002/pd.5045. View

18.

Massolo A, Romiti A, Viggiano M, Vassallo C, Ledingham M, Lanzone A . Fetal cardiac dimensions in congenital diaphragmatic hernia: relationship with gestational age and postnatal outcomes. J Perinatol. 2021; 41(7):1651-1659. DOI: 10.1038/s41372-021-00986-y. View

19.

Nair J, Lakshminrusimha S . Update on PPHN: mechanisms and treatment. Semin Perinatol. 2014; 38(2):78-91. PMC: 3942674. DOI: 10.1053/j.semperi.2013.11.004. View

20.

Gien J, Kinsella J . Management of pulmonary hypertension in infants with congenital diaphragmatic hernia. J Perinatol. 2016; 36 Suppl 2:S28-31. DOI: 10.1038/jp.2016.46. View